期刊文献+

反相离子对高效液相色谱法分析硫代反义寡核苷酸CT102相关杂质 被引量:1

Analysis on related impurities of antisense thio-oligonucleotide drug CT102 by ion-pair reversed phase high-performance liquid chromatography
原文传递
导出
摘要 目的:建立硫代反义寡核苷酸CT102及其相关杂质的反相离子对高效液相色谱(IP-RP-HPLC)分析方法。方法:对可能存在的3'n-1、5'n-1序列、5'(P=S/O)不完全硫代序列与CT102全长序列(n)的分离情况进行了考察,采用的色谱柱为XBridge OST C18 Column(50 mm×4.6 mm,2.5μm);流动相A为100 mmol.L-1 HFIP/31.6 mmol.L-1 TEA,10%甲醇(V/V));流动相B为100 mmol.L-1HFIP/31.6 mmol.L-1TEA,20%甲醇,洗脱梯度为0~12 min,17%→43%B;柱温为55℃;流速为0.4 mL.min-1;检测波长为260 nm。结果:在优化的条件下,合成过程中的主要杂质5'n-1、3'n-1以及5'(P=S/O)均能够实现与全长全硫代序列n基线分离。该法用于含量测定,CT102在50-600μg·mL-1浓度范围内线性良好,r=0.9999,检出限为2.5μg·mL-1,精密度与重现性良好,RSD小于2%,平均回收率为100.1%,(RSD=1.7%,n=9)。结论:该方法可应用于CT102原料药的纯度检测和含量测定,为该药物的深入研究提供保证。 Objective: To develop an ion-pair reversed phase high-performance liquid chromatography method(IP-RP-LC) for the analysis of an antisense thio-oligonucleotide drug CT102 and its related impurities.Methods: The full-length sequence of CT102 as well as the possibly existing sequences of 3'n-1 and 5'n-1 and the truncated thio-sequence of 5'(P = S / O) were investigated to study their separation conditions.HPLC separation was performed on a XBridge OST C18 Column(50 mm × 4.6 mm,2.5 μm);the mobile phase A and B were 100 mmol.L-1 HFIP /31.6 mmol.L-1 TEA-10% methanol(v / v) and 100 mmol.L-1 HFIP /31.6 mmol.L-1 TEA-20% methanol(v / v) for gradient elution with 17%→43% of solution B at 0-12 min;the column temperature was 55 oC,the flow rate 0.4 mL.min-1,the detection wavelength 260 nm.Results: Under the optimal condition,the main impurities,5'n-1 and 3'n-1together with 5'P = S / O could be completely separated from the full-length complete thio-sequence n baseline of CT102.By this method for content detection,a good linear relationship was obtained in the CT102 concentration range of 50-600 μg.mL-1(r =0.9999),the limits of detection was 2.5 μg.mL-1with satisfactory precision and reproducibility.RSD was less than 2%,and the average recovery was 100.1%(RSD = 1.7%,n = 9).Conclusion: The proposed IP-RP-HPLC method can be applied for the purity analysis and assay,providing foundation for further studies.
出处 《药物分析杂志》 CAS CSCD 北大核心 2013年第7期1157-1162,1167,共7页 Chinese Journal of Pharmaceutical Analysis
基金 "重大新药创制"科技重大专项"抗肝癌药物CT102的临床前研究"项目资助(2011ZX09102-001-07)
关键词 硫代反义寡核苷酸 CT102 反相离子对液相色谱 杂质分析 质谱分析 antisense thio-oligonucleotide CT102 ion-pair reversed phase liquid chromatography related impurity analysis MS
  • 相关文献

参考文献12

  • 1Nikcevic I,Wyrzykiewicz TK,Limbach PA.Detecting low-level synthesis impurities in modied phosphorothioate oligonucleotides using liquid chromatography–high resolution mass spectrometry.Int J Mass Spectrom.2010,304(2/3):67.
  • 2李麒麟,周建,王小行,高小平.用IE-HPLC、PAGE分析合成的硫代寡核苷酸相关物质“n-1”、“n-2”和“n-3”[J].药物分析杂志,2002,22(5):371-375. 被引量:3
  • 3Li S,Lu DD,Zhang YL,et al.An improved ion-pair reversed phase LC method for analysis of major impurities of phosphorothioate oligonucleotide cantide.Chromatographia,2010,72(3/4):215.
  • 4Dickman MJ.Effects of sequence and structure in the separation of nucleic acids using ion pair reverse phase liquid chromatography. J Chromatogr A,2005,(1076):83.
  • 5王一,肖志坚,刘澎,杨晨,杨仁池,蔡英林,韩忠朝.血管内皮细胞生长因子及其受体KDR、Flt1在急性髓系白血病中的表达及其意义[J].中华血液学杂志,2003,24(5):249-252. 被引量:19
  • 6Lin RX,Wang ZY,Zhang N,et al.Inhibition of hepatocellular carcinoma growth by antisense oligonucleotides to type I insulin-like growth factor receptor in vitro and in an orthotopic model.Hepatol Res,2007(37):366.
  • 7Lu Y.Recent advances in the stereocontrolled synthesis of antisense phosphorothioates.Mini Rev Med Chem,2006,6(3):319.
  • 8Gilar M,Belenky A,Cohen AS.Polymer solutions as a pseudostationary phase for capillary electrochromatographic separation of DNA diastereomers.Electrophoresis,2000,21(14):2999.
  • 9Fountain KJ,Gilar M,Gebler JC.Analysis of native and chemically modified oligonucleotides by tandem ion-pair reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.Rapid Commun.Mass Spectrom,2003,17(7):646.
  • 10Levin DS,Shepperd BT,Gruenloh CJ.Combining ion pairing agents for enhanced analysis of oligonucleotide therapeutics by reversed phase-ion pairing ultra performance liquid chromatography(UPLC).J Chromatogr B,2011,879(19):1587.

二级参考文献11

  • 1萨母布鲁克 弗里奇.分子克隆实验指南(第二版)[M].北京:科学出版社,1992.891.
  • 2夏令伟.核酸探针的合成、技术及应用[M].北京:科学出版社,1998.168.
  • 3李麒麟 周建 等.用离子交换高效液相色谱纯化合成的硫代反义寡核苷酸[J].药物分析杂志,2001,:47-47.
  • 4Steins MB, Pardro T, Bieker R, et al. Efficacy and safety of thalidomide in patients with acute myeloid leukemia. Blood, 2002,99:854-839.
  • 5Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res , 1999,59: 728-733.
  • 6Dias S,Ilattori K,Zhu Z, et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest,2000,106:511-521.
  • 7Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood, 2000, 96:2240-2245.
  • 8Katoh O, Takahashi T, Oguri T, et al. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor.Cancer Res,1998,58:5565-5569.
  • 9Aguayo A, Estey E, Kantarjian H, et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood, 1999,94:3717-3721.
  • 10Leung DW, Kuramoto K, Uesaka T, et al. ZK7, a novel zinc finger gene, is induced by vascular endothelial growth factor and inhibits apoptotic death in hematopoietic cells. Cancer Res, 2000,60:425-430.

共引文献20

同被引文献12

  • 1Belani CP, Nemunaitis J J, Chachoua A, et al. Phase 2 trial of erlo- tinib with or without PF-3512676 ( CPG 7909 ,a Toll-like receptor 9 agonist ) in patients with advanced recurrent EGFR-positive non-small cell lung cancer [ J ]. Cancer Boil Ther, 2013,14 (7) : 557-563.
  • 2Jassies-van der Lee A, Rutten V, Spiering R, et al. The immunos- timulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis [J]. Vet J,2014,200( 1 ) :103-108.
  • 3Minang JT, Inglefield JR, Harris AM ,et al. Enhanced early innate and T cell-mediated responses in subjects immunized withAnthrax Vaccine Adsorbed Plus CPG 7909 ( AV7909 ) [ J ]. Vaccine, 2014,32 ( 50 ) :6847- 6854.
  • 4Aranda F, Vacchelli E, Obrist F, et al. Trial Watch: Toll-like receptor agonists in ontological indications [ J ]. Oncolrnmunology, 2014,3(5 ) :29179.
  • 5Fearon KL,Stults JT,Bergot BJ,et al, Investigation of the ' n-1 ' impurity in phosphorothioate oligodeoxynucleotides synthesized by the solid-phase beta-cyanoethyl phosphoramidite method using stepwise sulfurization [ J ]. Nucleic Acids Res, 1995,23 ( lg ) : 2754-2761.
  • 6Nikcevic IR, Wyrzykiewicz TK, Limbach PA. Detecting low-level synthesis impurities in modified phosphorothioate oligonucleotides using liquid chromatography-high resolution mass spectrometry [ J ]. lnt J Mass Spectrom ,2011,304 ( 2-3 ) :98-104.
  • 7Chen B, Bartlett MG. Determination of therapeutic oligonucleoti- des using capillary gel electrophoresis [ J ]. Biomed Chromatogr, 2012 ,6 4)409-41.
  • 8Robert ER, leithner KA, Bemkop-Schntlrch AN, et al. Phosphorot- hioate Oligonueleotide Quantification by Ix-Liquid Chromatogra- phy-Mass Spectrometry [ J ]. The AAPS Journal, 2012,14 ( 4 ) : 728-737.
  • 9骆雪芳,尹小英,付静静,胡育筑.柱温和流速对反相离子对色谱法分析寡核苷酸的影响[J].分析化学,2008,36(5):627-631. 被引量:4
  • 10杨远,彭小华,林勇.CpG ODN对小鼠哮喘模型气道炎症及信号转导子和转录激活子6(STAT6)表达的影响[J].中国临床药理学与治疗学,2010,15(2):149-153. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部